WASHINGTON - US health regulators said Monday they had licensed a new treatment for multidrug-resistant tuberculosis -- the first such federal approval aimed at tackling the deadly disease in 40 years. The Food and Drug Administration (FDA) said it was approving the drug, named Sirturo, as an alternative treatment for adults suffering from TB when two more powerful medications that are available, isoniazid and rifampicin, do not work. But the regulator cautioned that the new drug should be used sparingly. "Sirturo provides much-needed treatment for patients who have don't have other therapeutic options available," announced Edward Cox of the Office of Antimicrobial Products in t...
Keep on reading: US regulators approve new tuberculosis drug
No comments:
Post a Comment